Literature DB >> 23463262

Chitosan-modified PLGA nanoparticles with versatile surface for improved drug delivery.

Yichao Wang1, Puwang Li, Lingxue Kong.   

Abstract

Shortage of functional groups on surface of poly(lactide-co-glycolide) (PLGA)-based drug delivery carriers always hampers its wide applications such as passive targeting and conjugation with targeting molecules. In this research, PLGA nanoparticles were modified with chitosan through physical adsorption and chemical binding methods. The surface charges were regulated by altering pH value in chitosan solutions. After the introduction of chitosan, zeta potential of the PLGA nanoparticle surface changed from negative charge to positive one, making the drug carriers more affinity to cancer cells. Functional groups were compared between PLGA nanoparticles and chitosan-modified PLGA nanoparticles. Amine groups were exhibited on PLGA nanoparticle surface after the chitosan modification as confirmed by Fourier transform infrared spectroscopy and X-ray photoelectron spectroscopy. The modified nanoparticles showed an initial burst release followed by a moderate and sustained release profile. Higher percentage of drugs from cumulative release can be achieved in the same prolonged time range. Therefore, PLGA nanoparticles modified by chitosan showed versatility of surface and a possible improvement in the efficacy of current PLGA-based drug delivery system.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23463262      PMCID: PMC3665987          DOI: 10.1208/s12249-013-9943-3

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  24 in total

1.  Influence of secondary preparative parameters and aging effects on PLGA particle size distribution: a sedimentation field flow fractionation investigation.

Authors:  Catia Contado; Eleonora Vighi; Alessandro Dalpiaz; Eliana Leo
Journal:  Anal Bioanal Chem       Date:  2012-05-27       Impact factor: 4.142

2.  Surface modification and characterization of chitosan or PLGA membrane with laminin by chemical and oxygen plasma treatment for neural regeneration.

Authors:  Yi-Cheng Huang; Chun-Chieh Huang; Yi-You Huang; Keh-Shaw Chen
Journal:  J Biomed Mater Res A       Date:  2007-09-15       Impact factor: 4.396

3.  Combining oxygen plasma treatment with anchorage of cationized gelatin for enhancing cell affinity of poly(lactide-co-glycolide).

Authors:  Hong Shen; Xixue Hu; Fei Yang; Jianzhong Bei; Shenguo Wang
Journal:  Biomaterials       Date:  2007-07-05       Impact factor: 12.479

4.  PLA/PLGA nanoparticles for sustained release of docetaxel.

Authors:  T Musumeci; C A Ventura; I Giannone; B Ruozi; L Montenegro; R Pignatello; G Puglisi
Journal:  Int J Pharm       Date:  2006-06-23       Impact factor: 5.875

5.  Vitamin E TPGS used as emulsifier in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel (Taxol).

Authors:  L Mu; S S Feng
Journal:  J Control Release       Date:  2002-04-23       Impact factor: 9.776

6.  Poly(L-lactide-co-glycolide) nanospheres conjugated with a nuclear localization signal for delivery of plasmid DNA.

Authors:  Oju Jeon; Hee-Won Lim; Minhyung Lee; Su Jin Song; Byung-Soo Kim
Journal:  J Drug Target       Date:  2007-04       Impact factor: 5.121

7.  Erythropoietin loaded microspheres prepared from biodegradable LPLG-PEO-LPLG triblock copolymers: protein stabilization and in-vitro release properties.

Authors:  M Morlock; T Kissel; Y X Li; H Koll; G Winter
Journal:  J Control Release       Date:  1998-12-04       Impact factor: 9.776

8.  Changes in cisplatin delivery due to surface-coated poly (lactic acid)-poly(epsilon-caprolactone) microspheres.

Authors:  Thomas Chandy; Robert F Wilson; Gundu H R Rao; Gladwin S Das
Journal:  J Biomater Appl       Date:  2002-04       Impact factor: 2.646

9.  Plasma-treated, collagen-anchored polylactone: Its cell affinity evaluation under shear or shear-free conditions.

Authors:  Jian Yang; Yuqing Wan; Junlin Yang; Jianzhong Bei; Shenguo Wang
Journal:  J Biomed Mater Res A       Date:  2003-12-15       Impact factor: 4.396

Review 10.  Application of chitin and chitosan derivatives in the pharmaceutical field.

Authors:  Yoshinori Kato; Hiraku Onishi; Yoshiharu Machida
Journal:  Curr Pharm Biotechnol       Date:  2003-10       Impact factor: 2.837

View more
  42 in total

1.  Elastin-PLGA hybrid electrospun nanofiber scaffolds for salivary epithelial cell self-organization and polarization.

Authors:  Zahraa I Foraida; Tim Kamaldinov; Deirdre A Nelson; Melinda Larsen; James Castracane
Journal:  Acta Biomater       Date:  2017-08-08       Impact factor: 8.947

2.  Inhibition of MDR1 gene expression and enhancing cellular uptake for effective colon cancer treatment using dual-surface-functionalized nanoparticles.

Authors:  Bo Xiao; Mingzhen Zhang; Emilie Viennois; Yuchen Zhang; Na Wei; Mark T Baker; Yunjin Jung; Didier Merlin
Journal:  Biomaterials       Date:  2015-02-11       Impact factor: 12.479

3.  iRGD-functionalized PEGylated nanoparticles for enhanced colon tumor accumulation and targeted drug delivery.

Authors:  Lijun Ma; Qiubing Chen; Panpan Ma; Moon Kwon Han; Zhigang Xu; Yuejun Kang; Bo Xiao; Didier Merlin
Journal:  Nanomedicine (Lond)       Date:  2017-07-26       Impact factor: 5.307

4.  Immunological Assessment of Chitosan or Trimethyl Chitosan-Coated PLGA Nanospheres Containing Fusion Antigen as the Novel Vaccine Candidates Against Tuberculosis.

Authors:  Sirwan Zare; Mona Kabiri; Yousef Amini; Adel Najafi; Fatemeh Mohammadpour; Seyed Hasan Ayati; Amin Reza Nikpoor; Mohsen Tafaghodi
Journal:  AAPS PharmSciTech       Date:  2021-12-10       Impact factor: 3.246

5.  Chitosan enhances nanoparticle delivery from the reproductive tract to target draining lymphoid organs.

Authors:  Jaehyung Park; Renuka Ramanathan; Linhchi Pham; Kim A Woodrow
Journal:  Nanomedicine       Date:  2017-04-20       Impact factor: 5.307

6.  Co-delivery of camptothecin and curcumin by cationic polymeric nanoparticles for synergistic colon cancer combination chemotherapy.

Authors:  Bo Xiao; Xiaoying Si; Moon Kwon Han; Emilie Viennois; Mingzhen Zhang; Didier Merlin
Journal:  J Mater Chem B       Date:  2015-09-01       Impact factor: 6.331

Review 7.  A Review on Chitosan's Uses as Biomaterial: Tissue Engineering, Drug Delivery Systems and Cancer Treatment.

Authors:  Rayssa de Sousa Victor; Adillys Marcelo da Cunha Santos; Bianca Viana de Sousa; Gelmires de Araújo Neves; Lisiane Navarro de Lima Santana; Romualdo Rodrigues Menezes
Journal:  Materials (Basel)       Date:  2020-11-06       Impact factor: 3.623

8.  Hyaluronic acid-functionalized polymeric nanoparticles for colon cancer-targeted combination chemotherapy.

Authors:  Bo Xiao; Moon Kwon Han; Emilie Viennois; Lixin Wang; Mingzhen Zhang; Xiaoying Si; Didier Merlin
Journal:  Nanoscale       Date:  2015-10-12       Impact factor: 7.790

9.  Biodegradable PEG-poly(ω-pentadecalactone-co-p-dioxanone) nanoparticles for enhanced and sustained drug delivery to treat brain tumors.

Authors:  Evan M Chen; Amanda R Quijano; Young-Eun Seo; Christopher Jackson; Alexander D Josowitz; Seth Noorbakhsh; Andrea Merlettini; Ranjini K Sundaram; Maria Letizia Focarete; Zhaozhong Jiang; Ranjit S Bindra; W Mark Saltzman
Journal:  Biomaterials       Date:  2018-06-18       Impact factor: 12.479

10.  Lipoprotein-Inspired Nanocarrier Composed of Folic Acid-Modified Protein and Lipids: Preparation and Evaluation of Tumor-Targeting Effect.

Authors:  Mengmeng Han; Xiaoman Ji; Jianfei Li; Zhiming Ge; Bin Luo; Kai Zhou; Qianqian Wang; Xin Sun; Wei Zhang; Jin Li
Journal:  Int J Nanomedicine       Date:  2020-05-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.